Aripiprazole for the management of schizophrenia in the Japanese population: a systematic review and meta-analysis of randomized controlled trials
Taro Kishi, Yuki Matsuda, Shinji Matsunaga, Nakao Iwata Department of Psychiatry, Fujita Health University School of Medicine, Toyoake, Aichi, Japan Background: We conducted a systematic review and meta-analysis of randomized controlled trials comparing aripiprazole with pooled antipsychotics in...
Saved in:
| Main Authors: | Kishi T, Matsuda Y, Matsunaga S, Iwata N |
|---|---|
| Format: | article |
| Language: | EN |
| Published: |
Dove Medical Press
2015
|
| Subjects: | |
| Online Access: | https://doaj.org/article/a4c3798490b54d0498bc314e7e68527a |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Efficacy and tolerability of aripiprazole once monthly for schizophrenia: a systematic review and meta-analysis of randomized controlled trials
by: Oya K, et al.
Published: (2015) -
A randomized trial of aripiprazole vs blonanserin for the treatment of acute schizophrenia and related disorders
by: Kishi T, et al.
Published: (2016) -
Iminodibenzyl class antipsychotics for schizophrenia: a systematic review and meta-analysis of carpipramine, clocapramine, and mosapramine
by: Kishi T, et al.
Published: (2014) -
Comparative efficacy and safety of antipsychotics in the treatment of schizophrenia: a network meta-analysis in a Japanese population
by: Kishi T, et al.
Published: (2017) -
Efficacy and tolerability of topiramate-augmentation therapy for schizophrenia: a systematic review and meta-analysis of randomized controlled trials
by: Okuyama Y, et al.
Published: (2016)